research "A literature review on “Triphala’s Rasayana Karmukata."
Triphala is a safe herbal remedy that aids digestion, cleanses the colon, boosts immunity, and may have anti-cancer benefits.
Search
for
Sort by
Research
60-90 / 1000+ results
research INDRALUPTA (ALOPECIA AREATA) MANAGEMENT BY PRACCHANA AND CUPPING: A SUCCESS STORY
A man regrew hair in 15 days using Pracchana and cupping therapy.
research Ayurvedic Management of Indralupta with special reference to Alopecia Areata: A Case Report
Ayurvedic treatment successfully regrew hair in a woman with alopecia areata.
research Management of Indralupta with Pracchana- A Case Study
Ayurvedic treatment effectively improved patchy hair loss in a 25-year-old male.
research Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.
research Nasya Karma in Cosmetology: An Anatomical Approach - A Natural Solution for Skin and Hair Wellness
Nasya Karma can improve skin and hair health.
research An Open Randomised Clinical Study to Evaluate the Combined Effect of Krishna Tila Kashayam and Shatapuspa Choornam in PCOS
The treatment improved menstrual flow and reduced ovarian cysts in mild to moderate PCOS cases.
research Ayurvedic Management of Pakshmashata (Madarosis): A Case Report
Ayurvedic treatment helped a woman regrow her lost eyebrow and eyelash hair.
research A Case Study on Indralupta
Ayurvedic treatments effectively and permanently treated hair loss in a week.
research MANAGEMENT OF KHALITYA WITH MALATYADI TAILAM: A CASE STUDY
Malatyadi tailam effectively improved hair fall, dryness, and thinness in a patient.
research Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
Ritlecitinib is an effective new treatment for Alopecia Areata.
research Management of Indralupta (Alopecia areata) through Ayurveda - A Case Report
Ayurvedic treatment led to significant hair regrowth in an 11-year-old with alopecia areata.
research A RANDOMIZED OPEN LABELLED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF PRACHHANNA FOLLOWED BY GUNJA LEPA AND PRP THERAPY FOLLOWED BY APPLICATION OF MINOXIDIL SOLUTION IN THE MANAGEMENT OF INDRALUPTA W.S.R TO ALOPECIA AREATA- A COMPARITIVE CLINICAL STUDY
Prachhanna followed by Guñjā lepa is more effective for treating alopecia areata than PRP with Minoxidil.
research A RANDOMIZED OPEN LABELLED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF PRACHHANNA FOLLOWED BY GUNJA LEPA AND PRP THERAPY FOLLOWED BY APPLICATION OF MINOXIDIL SOLUTION IN THE MANAGEMENT OF INDRALUPTA W.S.R TO ALOPECIA AREATA- A COMPARITIVE CLINICAL STUDY
Prachhanna followed by Guñjā lepa is more effective for treating alopecia areata than PRP with Minoxidil.
research DERMATOLOGIC INVESTIGATION OF ALOPECIA IN RHESUS MACAQUES (MACACA MULATTA)
Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.
research Effect of Madayantika Siddha Taila in Darunaka W.S.R. to Seborrhea Capitis
Madayantika Siddha Taila is effective for treating Seborrhea capitis.
research Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair
Ritlecitinib significantly regrows scalp hair in people with alopecia areata.
research Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.
research Raltegravir-Induced Alopecia in an HIV+ Patient
Raltegravir may cause hair loss in some patients.
research Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata
Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.
research Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.
research Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata
Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.
research Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.
research Toxicity studies of iron-containing ayurvedic drug Kasisa Bhasma
Kasisa Bhasma is safer and nontoxic compared to Shodhita Kasisa.
research Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.
research STUDY ON KESHA SHAREERA W.S.R TO KHALITYA (MALE PATTERN BALDNESS) IN RELATION WITH DAIHIKA PRAKRUTI.
Certain Prakruti types are more prone to early male pattern baldness.
research Effect of Gandharvahastadi Kwath in Virechana Krama in the Management of Thyroid Dysfunction
Ayurvedic treatment with Gandharvahastadi Kwath improved thyroid dysfunction symptoms.
research Alopecia areata in a rhesus monkey (Macaca mulatta)
The monkey's hair loss was due to an autoimmune disease, not genetics.
research Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study
Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.
research Alopecia areata and ritlecitinib: Unravelling response trajectories
Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.